文献速递心境障碍

细胞周期蛋白依赖性激酶5功能异常通过改变伏隔核DARPP-32磷酸化状态促进亨廷顿病抑郁样行为

Cyclin-Dependent Kinase 5 Dysfunction Contributes to Depressive-like Behaviors in Huntington's Disease by Altering the DARPP-32 Phosphorylation Status in the Nucleus Accumbens.
PubMed 文献 · Biol Psychiatry · 2019-03-13

该研究在Hdh+/Q111敲入突变小鼠中评估Cdk5抑制对抑郁样和焦虑样行为的影响,并探讨DARPP-32/β-adducin信号机制。结果显示突变小鼠自2月龄起出现抑郁样而非焦虑样行为,抑制Cdk5可预防抑郁样行为并降低伏隔核DARPP-32 Thr75磷酸化,DARPP-32 Thr75Ala杂合突变小鼠对抑郁样行为具有抵抗性。

要点

  • Hdh+/Q111小鼠自2月龄起出现抑郁样行为,但无焦虑样行为。
  • 伏隔核Cdk5抑制可预防抑郁样行为并降低DARPP-32 Thr75磷酸化。
  • DARPP-32 Thr75Ala杂合突变使Hdh+/Q111小鼠抵抗抑郁样行为。

核心结论

  • 伏隔核Cdk5通过改变DARPP-32/β-adducin信号并破坏树突棘细胞骨架,促进亨廷顿病小鼠的抑郁样行为。

研究设计与样本

  • 研究使用Hdh+/Q111敲入突变小鼠进行一系列行为学测试,并开展生化与形态学研究。
  • 研究构建了huntingtin/DARPP-32双敲入突变小鼠以分析DARPP-32在亨廷顿病抑郁中的作用。

主要发现

  • Hdh+/Q111突变小鼠自2月龄起表现出抑郁样行为,但未表现出焦虑样行为。
  • 通过roscovitine输注抑制Cdk5可预防抑郁样行为并降低伏隔核DARPP-32 Thr75磷酸化。
  • DARPP-32 Thr75Ala点突变杂合的Hdh+/Q111小鼠对抑郁样行为具有抵抗性。
  • β-adducin磷酸化被确定为Cdk5下游机制,可能介导伏隔核树突棘结构可塑性变化和抑郁样行为。

临床怎么用

  • 伏隔核Cdk5可能作为亨廷顿病抑郁治疗的潜在靶点,但尚需临床验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Depression is the most common psychiatric condition in Huntington's disease (HD), with rates more than twice those found in the general population. At the present time, there is no established molecular evidence to use as a basis for depression treatment in HD. Indeed, in some patients, classic antidepressant drugs exacerbate chorea or anxiety. Cyclin-dependent kinase 5 (Cdk5) has been involved in processes associated with anxiety and depression. This study evaluated the involvement of Cdk5 in the development and prevalence of depressive-like behaviors in HD and aimed to validate Cdk5 as a target for depression treatment. METHODS: We evaluated the impact of pharmacological inhibition of Cdk5 in depressive-like and anxiety-like behaviors in Hdh+/Q111 knock-in mutant mice by using a battery of behavioral tests. Biochemical and morphological studies were performed to define the molecular mechanisms acting downstream of Cdk5 activation. A double huntingtin/DARPP-32 (dopamine- and cAMP-regulated phosphoprotein 32) knock-in mutant mouse was generated to analyze the role of DARPP-32 in HD depression. RESULTS: We found that Hdh+/Q111 mutant mice exhibited depressive-like, but not anxiety-like, behaviors starting at 2 months of age. Cdk5 inhibition by roscovitine infusion prevented depressive-like behavior and reduced DARPP-32 phosphorylation at Thr75 in the nucleus accumbens. Hdh+/Q111 mice heterozygous for DARPP-32 Thr75Ala point mutation were resistant to depressive-like behaviors. We identified β-adducin phosphorylation as a Cdk5 downstream mechanism potentially mediating structural spine plasticity changes in the nucleus accumbens and depressive-like behavior. CONCLUSIONS: These results point to Cdk5 in the nucleus accumbens as a critical contributor to depressive-like behaviors in HD mice by altering DARPP-32/β-adducin signaling and disrupting the dendritic spine cytoskeleton.

来源:Biol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Brito V, Giralt A, Masana M, et al. Cyclin-Dependent Kinase 5 Dysfunction Contributes to Depressive-like Behaviors in Huntington's Disease by Altering the DARPP-32 Phosphorylation Status in the Nucleus Accumbens. Biol Psychiatry. 2019. PMID: 31060804. doi:10.1016/j.biopsych.2019.03.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。